69C Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Tvardi Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1 EUR 2.04% Market Closed

Market Cap: €54.7m

T	Tvardi Therapeutics Inc F:69C	US
N	Nordnet AB (publ) STO:SAVE	SE
	Endurance Motive SA F:7VB	ES
	Karat Packaging Inc NASDAQ:KRT	US
D	Daewon Kangup Co Ltd KRX:000430	KR
R	Repsol SA SWB:REPA	ES
B	Birchcliff Energy Ltd F:39B	CA
C	Compagnie Financiere Tradition SA SWB:CFI	CH
T	Telefonica SA XMUN:TNE2	ES
	BACHEM HOLDING AG OTC:BCHMF	CH
	Apollo Commercial Real Estate Finance Inc NYSE:ARI	US
H	Haseko Corp F:HS6	JP

Profitability Summary

Tvardi Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

48%

Low Operating Margin

Negative 3Y Average Operating Margin

-903%

Low Net Margin

Negative 3Y Average Net Margin

-850%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-414%

Negative ROE

-126%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-34%

ROIC is Increasing

-336% > 2 130%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.